Table 2 The genotype and allele frequencies of CD40 polymorphism in SLE patients and controls
Polymorphism | Control subjects n = 220 (%) | SLE patients n = 205 (%) | χ 2 | P value |
|---|---|---|---|---|
rs1883832 C/T | ||||
CC | 79 (35.9) | 47 (22.9) | 9.504 | 0.009 |
CT | 101 (45.9) | 105 (51.2) | ||
TT | 40 (18.2) | 53 (25.9) | ||
C | 259 (58.9) | 199 (48.5) | 9.109 | 0.003 |
T | 181 (41.1) | 211 (51.5) | ||
rs1569723 A/C | ||||
AA | 54 (24.5) | 51 (24.9) | 0.284 | 0.868 |
AC | 105 (47.7) | 93 (45.4) | ||
CC | 61 (27.7) | 61 (29.8) | ||
A | 213 (48.4) | 195 (47.6) | 0.061 | 0.805 |
C | 227 (51.6) | 215 (52.4) | ||
rs4810485 G/T | ||||
GG | 56 (25.5) | 52 (25.4) | 0.341 | 0.843 |
GT | 107 (48.6) | 95 (46.3) | ||
TT | 57 (25.9) | 58 (28.3) | ||
G | 219 (49.8) | 199 (48.5) | 0.130 | 0.719 |
T | 221 (50.2) | 211 (51.5) |